The specific involvement of EPS8/ABI1/SOS1 tri-complex in ovarian cancer metastasis suggests that this tri-complex-targeted drugs may have less effects on non-cancer tissues than on cancer tissues. This evidence concerns the gene EPS8 and ovarian carcinoma.